Sign in
4

Changes in Ownership

Arbutus Biopharma Corp Filed Acc 0001140361-15-035079

President & CEO acquired 219,428 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Murray Mark J. · President & CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2015-09-11 Exercise or conversion : show line 1 in the form +219,428 $0.44 $97,514 284,389 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2015-09-11 Exercise or conversion : show line 2 in the form Employee Stock Option (right to buy) −219,428 0 D
Loading xslF345X03/doc1.xml…